Sponsors

Lead Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)

This study is a longitudinal and cross-sectional evaluation of patients with Chronic Granulomatous Disease (CGD) who received or are receiving hematopoietic cell transplantation (HCT) for their disease under a variety of protocols used by participating institutions compared to a control non-HCT group receiving standard care. Investigators at multiple centers caring for patients with CGD in North America and 3 centers in Europe will participate. Patients with CGD will have been treated according to institutional practice and protocols. Investigators will enroll these patients as subjects in this protocol. This study will investigate which patients benefit most from HCT, and what types of transplants are optimal for patients with CGD, in the context of overall outcomes in CGD patients with and without transplant.

Related studies

RECRUITINGPhase 1/2

Allogeneic Hematopoietic Stem Cell Transplantation for Chronic Granulomatous Disease (CGD) With an Alemtuzumab, Busulfan and TBI-based Conditioning Regimen Combined With Cytokine (IL-6, +/- IFN-gamma) Antagonists

NCT05463133 · Chronic Granulomatous Disease

RECRUITINGPhase 2

Hematopoietic Stem Cell Transplantation (HSCT) for Common Variable Immunodeficiency (CVID) and Other Autoimmune Manifestations of Primary Immune Regulatory Disorders (PIRD)

NCT07284641 · Common Variable Immunodeficiency (CVID), Primary Immune Regulatory Disorder, and more

Enrolling By InvitationPhase 1/2

Analysis of Patients Treated for Chronic Granulomatous Disease Since January 1, 1995

What this study is about

Clareo turns complex medical information into clear understanding you can use.

Sponsors

Related studies

Allogeneic Hematopoietic Stem Cell Transplantation for Chronic Granulomatous Disease (CGD) With an Alemtuzumab, Busulfan and TBI-based Conditioning Regimen Combined With Cytokine (IL-6, +/- IFN-gamma) Antagonists

Hematopoietic Stem Cell Transplantation (HSCT) for Common Variable Immunodeficiency (CVID) and Other Autoimmune Manifestations of Primary Immune Regulatory Disorders (PIRD)

Sequential Cadaveric Lung and Bone Marrow Transplant for Immune Deficiency Diseases

Study to Assess the Use of JSP191 in Matched Unrelated Donor Transplantation for Chronic Granulomatous Disease (CGD)

Study of Voicing My CHOiCES as a Tool for Advanced Care Planning in Young Adults With Cancer

Trial snapshot

Condition

Locations shown

For caregivers